Announcements Trials
Browse Landscape

Phase

Phase NA 12Phase 2 3Phase 1 3Phase 3 2Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 4Thoracic 3Other hematologic neoplasm 3Genitourinary 3Gastrointestinal 3Dermatologic 3Breast 3Plasma cell 2Myeloid 2Gynecologic 2Sarcoma 1

Conditions

Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Postoperative Complications 1Peritoneal Neoplasms 1Infections 1Endometrial Neoplasms 1

Interventions

Paclitaxel 150Carboplatin 110Cisplatin 95Bevacizumab 42Topotecan 39Gemcitabine 38liposomal doxorubicin 34Radiotherapy 29Doxorubicin 27Brachytherapy 26Taxes 24pembrolizumab 20olaparib 20Drug Therapy 20Hyperthermic Intraperitoneal Chemotherapy 16Chemotherapy, Adjuvant 16human papillomavirus vaccine, L1 type 16, 18 15Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14Docetaxel 13Neoadjuvant Therapy 12Platinum 10niraparib 9Radiation 91,2-diaminocyclohexaneplatinum II citrate 9Vaccines, Synthetic 8Surgical Procedures, Operative 8atezolizumab 7Specimen Handling 7Papillomavirus Vaccines 7Letrozole 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Therapeutics × Gynecologic × Clear all
NCT02840331 2017-10-27

Hypericin-PDT

University Hospital Tuebingen

Phase 3 Unknown
50 enrolled
GastrointestinalGynecologic

Peritoneal Neoplasms, Stomach Neoplasms

NCT00003267 2012-07-11

Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 3 Completed
214 enrolled
Gynecologic

Uterine Cervical Neoplasms, Infections, Postoperative Complications, Vaginal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡